Cardiovascular Manifestations of Kawasaki Disease: Update in 2017
1/27/2017 6:45 AM to 1/27/2017 8:15 AM
3/28/2018 10:03 AM
Password or Payment Required
At the conclusion of this presentation, attendees are expected to:
- Recognize the acute cardiac manifestations of Kawasaki Disease
- Understand the late cardiac complications of Kawasaki Disease
- Be familiar with the management strategies for Kawasaki Disease
Accreditation Statement: The Miami Children’s Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: The Miami Children’s Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty/Planner Disclosure Policy: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.
Commercial Support Disclosure: No Commercial Support was received for this activity.
The Planning Committee and Staff have no conflicts of interest to declare.
Dr. Lopez (or spouse/partner) has not had (in the past 12 months) any conflicts of interest to resolve or relevant financial relationship with the manufacturers of products or services that will be discussed in this CME activity or in his presentation.
Dr. Lopez will support this presentation and clinical recommendations with the “best available evidence” from medical literature.
Dr. Lopez’s presentation will involve comments or discussion concerning the unapproved or off-label uses of: Infliximab, Adalimumab, and Etarnecept in Kawasaki Disease.